Understanding the complex landscape of bioconjugates

Bioconjugates are a rapidly expanding therapeutic modality demonstrating tremendous benefit for cancer patients already, and with significant promise in inflammatory, infectious and rare diseases. Key to the successful development of bioconjugates is the selection of an appropriate conjugation strategy.

In this eBook, Dr. Nicolas Camper, Vice President, and Dr. Petra Dieterich, Senior Vice President & Scientific Leader, Abzena, review and discuss the main categories of therapeutic bioconjugates, focusing on their key required characteristics or target product profile (TPP). Including, key considerations for selecting the most appropriate conjugation strategy for each application and insights into technological options along with real-world examples of bioconjugates in clinical development and in-market.

Download this SelectScience guide to explore how to:

• Understand the major categories of therapeutic bioconjugates
• Identify the essential characteristics that define a strong target product profile (TPP) for bioconjugate therapeutics, and why these attributes guide development success
• Learn how to select the most appropriate conjugation strategy for a given therapeutic goal, considering stability, efficacy, and manufacturability.
• Uncover current technological options and real‑world examples of bioconjugates in clinical development and on the market.

Resource details:

• Document type: SelectScience guide
• Page count: 25
• Read time: 37.5 mins